The global endobronchial valves market, valued at USD 171.15 million in 2023, is projected to expand at a compound annual growth rate (CAGR) of 5.9% during the forecast period from 2024 to 2032. By 2032, the market is expected to reach a valuation of USD 284.76 million. This growth is fueled by rising cases of chronic obstructive pulmonary disease (COPD), the increasing adoption of minimally invasive procedures, advancements in bronchoscopic technology, and a growing geriatric population vulnerable to lung conditions.
Endobronchial valves are one-way valves implanted into the airways of the lungs to block airflow to diseased parts of the lung and redirect it to healthier regions. This bronchoscopic lung volume reduction technique offers a safer, less invasive alternative to traditional surgery, significantly improving quality of life for patients suffering from severe emphysema or chronic bronchitis.
Market Overview
Endobronchial valves have become an essential therapeutic option in pulmonary medicine, particularly for patients with advanced-stage COPD. These devices are used in endoscopic lung volume reduction (ELVR) procedures, which help to reduce hyperinflation in emphysematous lungs and improve lung function, exercise capacity, and overall patient well-being.
The market’s growth is being driven by increasing global awareness of non-surgical treatment options, higher diagnosis rates of COPD, and greater access to advanced interventional pulmonology technologies in both developed and emerging economies. Moreover, the expansion of insurance coverage for bronchoscopic valve procedures in countries like the United States and Germany has played a pivotal role in the growing number of procedures being performed.
Market Segmentation
By Product Type
-
Duckbill Valves
-
Umbrella Valves
-
Others (e.g., Customized/Hybrid Valves)
Duckbill valves dominate the market due to their flexible design and widespread clinical usage in lung volume reduction therapies. Their effectiveness in isolating target lobes with minimal complications has made them the preferred choice for bronchoscopists worldwide.
Umbrella valves, though less commonly used, are gaining traction in specific use cases due to their structural integrity and ability to conform to varied airway anatomies. Continued R&D in valve design is expected to expand this segment further.
By Application
-
Emphysema
-
Chronic Bronchitis
-
Other COPD Conditions
-
Post-Surgical Air Leaks
The emphysema segment is the largest application area, accounting for more than 65% of market share in 2023. Endobronchial valves have proven particularly effective in treating this form of COPD by collapsing hyperinflated lung regions and allowing healthier lung tissue to function more efficiently.
The post-surgical air leaks segment is expected to grow rapidly, especially in hospitals and thoracic surgery units, where valves are increasingly used as a temporary measure to resolve air leaks following lung resection surgeries.
By End User
-
Hospitals
-
Pulmonology Clinics
-
Ambulatory Surgical Centers (ASCs)
-
Research & Academic Institutions
Hospitals dominate the market due to their advanced infrastructure, access to trained specialists, and ability to perform complex procedures with post-operative monitoring. However, pulmonology clinics are emerging as important players as outpatient bronchoscopic procedures become more common.
Regional Analysis
North America
North America leads the global endobronchial valves market, with the United States accounting for the majority share. High prevalence of COPD, favorable reimbursement policies, and early adoption of advanced bronchoscopic techniques are contributing to market growth. The presence of leading device manufacturers and an expanding number of interventional pulmonologists further support regional development.
Europe
Europe follows closely behind, with countries such as Germany, the U.K., and France being key contributors. In Germany, statutory health insurance now covers ELVR procedures using endobronchial valves, significantly improving access. Strong clinical research activity and regulatory support from bodies like CE (Conformité Européenne) also drive adoption.
Asia-Pacific
The Asia-Pacific region is projected to exhibit the fastest growth during the forecast period, fueled by increasing awareness, growing geriatric populations, and a rise in smoking-related respiratory diseases. Countries such as China, Japan, South Korea, and India are focusing on upgrading healthcare infrastructure and training specialists in minimally invasive respiratory procedures.
Latin America and the Middle East & Africa (MEA)
These regions are still at a nascent stage but are expected to grow steadily with improved diagnostic rates and investments in public healthcare. Increasing medical tourism and partnerships with global manufacturers are contributing to the slow yet positive uptake of bronchoscopic interventions.
Key Companies in the Endobronchial Valves Market
The global endobronchial valves market is moderately consolidated, with a few key players holding significant market share. These companies are continuously investing in product innovation, regulatory approvals, clinical trials, and global expansion.
Leading Companies Include:
-
Pulmonx Corporation
– A global leader known for its Zephyr® Endobronchial Valve, which is FDA-approved and CE-marked. Pulmonx’s commitment to clinical research and physician training has made it a frontrunner in ELVR procedures. -
Olympus Corporation
– A renowned medical technology company with a wide portfolio of bronchoscopic tools, including endobronchial valve systems under development or regional licensing. Olympus is expanding its interventional pulmonology offerings through R&D and acquisitions. -
Spiration Inc. (a subsidiary of Olympus)
– Developer of the Spiration® Valve System, which has gained FDA approval for the treatment of severe emphysema. The company focuses on specialized valve design and has strong clinical support. -
Pulmodyne Inc.
– Known for offering advanced airway management solutions, Pulmodyne has also ventured into the bronchial valve space, catering to emergency and critical care applications. -
Boston Scientific Corporation
– While primarily focused on cardiology and urology, Boston Scientific is exploring opportunities in pulmonary interventions through strategic partnerships and innovation. -
Merit Medical Systems, Inc.
– Actively expanding its presence in pulmonary and thoracic procedures, Merit Medical offers minimally invasive solutions that align with valve implantation techniques.
Key Trends in the Market
-
Rising Preference for Non-Surgical Therapies: The global shift toward minimally invasive medical procedures is significantly benefiting the endobronchial valves market.
-
Reimbursement Expansion: Inclusion of valve therapy under public and private health insurance schemes in developed markets is encouraging broader adoption.
-
Growing Clinical Evidence: Results from multicenter trials like LIBERATE and EMPROVE continue to reinforce the efficacy and safety of endobronchial valve therapy in eligible patients.
-
Device Miniaturization & Design Innovation: Manufacturers are developing next-generation valves with improved deployment systems and compatibility across diverse airway anatomies.
-
Integration of AI & Imaging: AI-powered imaging technologies are being increasingly used for patient selection, pre-procedure planning, and outcome prediction in ELVR.
Explore More:
https://www.polarismarketresearch.com/industry-analysis/endobronchial-valves-market
Future Outlook
As the burden of COPD and emphysema continues to rise globally, and awareness of non-surgical treatment options spreads, the demand for endobronchial valves is poised for sustainable long-term growth. Companies are expected to focus on expanding access through cost-effective devices, training programs, and strategic geographic expansion.
In addition, regulatory support for fast-track approvals and coverage of bronchoscopic procedures will play a key role in accelerating the adoption of these life-enhancing devices, especially in middle-income countries.
More Trending Latest Reports By Polaris Market Research:
Lawn & Garden Consumables Market
Smokeless Tobacco Products Market
Fishing Apparel and Equipment Market
Pre-owned Luxury Watches Market
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek